Allogeneic CD6 Chimeric Antigen Receptor T Regulatory Cells therapy (City of Hope Medical Center)

N/A

Report date: 2026/04/21 20:00:18

Base Information

Drug NameAllogeneic CD6 Chimeric Antigen Receptor T Regulatory Cells therapy (City of Hope Medical Center)
Drug Alias NameCD6-CAR Tregs
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy
Mechanisms of ActionAnti-CD6
TargetsT-cell differentiation antigen CD6
Therapy Area/IndicationsGraft vs Host DiseaseDiabetes Mellitus, Type 1Hemic and Lymphatic Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesCity Of Hope National Medical Center
China Registration ClassN/A

Develop Information

Active CompaniesCity Of Hope National Medical Center
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 1
Inactive IndicationsGraft vs Host DiseaseHemic and Lymphatic Diseases

Other Information

ATC CodeN/A
Related LinksN/A